Corporate Profile

Intrexon Corporation, founded in 1998, is a leader in synthetic biology focused on collaborating with companies in human and animal health, food and agriculture, energy and chemicals, environment, and consumer products markets to create biologically based products that improve quality of life and the health of the planet. At present rates of global industrialization and population growth, food and energy supplies and environmental and healthcare resources are becoming scarcer. We believe Intrexon’s leading Better DNA® approach to synthetic biology has the potential to provide new, more effective and sustainable solutions to address these challenges. 

With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Working with key collaborators, Intrexon seeks to develop high value applications that can bring better medicines to more people, alleviate shortages of essential nutrients, develop renewable fuels and other resources, and protect the environment.

AquaBounty Distribution
Recent Press Releases
Apr 16, 2018

Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation (NYSE: XON) committed to enabling the study of life-threatening human diseases, today announced the U.S. Food & Drug...

Mar 29, 2018

ActoBio Therapeutics, a wholly owned subsidiary of Intrexon Corporation (NYSE: XON) and innovative biotechnology company focused on a new class of orally delivered biopharmaceuticals, and Intrexon...

Mar 1, 2018

Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced its fourth quarter and full...

Feb 22, 2018

Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced it will release fourth...

More >>

Investor Contact

Thomas Shrader, PhD
Vice President, Communications & Strategy
Intrexon Corporation
investors@intrexon.com

 


print email